Bridgeway Capital Management’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $281K | Hold |
|
|||||
|
2025
Q2 | $279K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $670K | Sell |
|
|||||
|
2024
Q3 | $559K | Hold |
|
|||||
|
2024
Q2 | $500K | Sell |
|
|||||
|
2024
Q1 | $131K | Sell |
|
|||||
|
2023
Q4 | $195K | Hold |
|
|||||
|
2023
Q3 | $123K | Hold |
|
|||||
|
2023
Q2 | $167K | Sell |
|
|||||
|
2023
Q1 | $182K | Hold |
|
|||||
|
2022
Q4 | $238K | Hold |
|
|||||
|
2022
Q3 | $417K | Hold |
|
|||||
|
2022
Q2 | $430K | Buy |
|
|||||
|
2022
Q1 | $382K | Buy |
|